243 related articles for article (PubMed ID: 24603453)
1. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age.
Allyse M; Sayres LC; Goodspeed TA; Cho MK
J Perinatol; 2014 Jun; 34(6):429-34. PubMed ID: 24603453
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
3. Demographic and experiential correlates of public attitudes towards cell-free fetal DNA screening.
Sayres LC; Allyse M; Goodspeed TA; Cho MK
J Genet Couns; 2014 Dec; 23(6):957-67. PubMed ID: 24715419
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prenatal testing for trisomy 21: a cross-sectional survey of service users' views and likely uptake.
Lewis C; Hill M; Silcock C; Daley R; Chitty LS
BJOG; 2014 Apr; 121(5):582-94. PubMed ID: 24433394
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive prenatal screening for trisomy 21: Consumers' perspectives.
Higuchi EC; Sheldon JP; Zikmund-Fisher BJ; Yashar BM
Am J Med Genet A; 2016 Feb; 170A(2):375-385. PubMed ID: 26553705
[TBL] [Abstract][Full Text] [Related]
7. Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context.
Allyse M; Sayres LC; King JS; Norton ME; Cho MK
Hum Reprod; 2012 Nov; 27(11):3123-31. PubMed ID: 22863603
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
9. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
10. Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
Obstet Gynecol; 2015 Sep; 126(3):691-692. PubMed ID: 26287784
[TBL] [Abstract][Full Text] [Related]
11. The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.
Mackie FL; Hemming K; Allen S; Morris RK; Kilby MD
BJOG; 2017 Jan; 124(1):32-46. PubMed ID: 27245374
[TBL] [Abstract][Full Text] [Related]
12. "This lifetime commitment": Public conceptions of disability and noninvasive prenatal genetic screening.
Steinbach RJ; Allyse M; Michie M; Liu EY; Cho MK
Am J Med Genet A; 2016 Feb; 170A(2):363-374. PubMed ID: 26566970
[TBL] [Abstract][Full Text] [Related]
13. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy.
Fosler L; Winters P; Jones KW; Curnow KJ; Sehnert AJ; Bhatt S; Platt LD
Ultrasound Obstet Gynecol; 2017 Apr; 49(4):470-477. PubMed ID: 27194226
[TBL] [Abstract][Full Text] [Related]
14. Committee Opinion No. 640: Cell-Free DNA Screening For Fetal Aneuploidy.
Obstet Gynecol; 2015 Sep; 126(3):e31-e37. PubMed ID: 26287791
[TBL] [Abstract][Full Text] [Related]
15. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
16. No. 261-Prenatal Screening for Fetal Aneuploidy in Singleton Pregnancies.
Chitayat D; Langlois S; Wilson RD
J Obstet Gynaecol Can; 2017 Sep; 39(9):e380-e394. PubMed ID: 28859781
[TBL] [Abstract][Full Text] [Related]
17. Genetic counselors' experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy.
Horsting JM; Dlouhy SR; Hanson K; Quaid K; Bai S; Hines KA
J Genet Couns; 2014 Jun; 23(3):377-400. PubMed ID: 24352524
[TBL] [Abstract][Full Text] [Related]
18. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
19. [Combined first trimester screening and cell-free fetal DNA - “next generation screening”].
Kagan KO; Eiben B; Kozlowski P
Ultraschall Med; 2014 Jun; 35(3):229-36. PubMed ID: 24764214
[TBL] [Abstract][Full Text] [Related]
20. The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice.
Suskin E; Hercher L; Aaron KE; Bajaj K
J Genet Couns; 2016 Oct; 25(5):1032-43. PubMed ID: 26879922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
